KVUE Stock Price Today (July 2026) — KVUE Analysis & Key Metrics 2026-07-17
KVUE (KVUE) is trading at $18.98, down 0.21% today (as of July 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Software growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $19.50 (2.7% upside).
- Volatility remains elevated (20.25% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (4.50% YoY) alongside significant competitive pressures.
KVUE Stock Analysis: Key Metrics & Valuation (July 2026)
Concise, actionable data for investors
KVUE - Historical Price & Volume
Market Cap
Enterprise Value: $45.80B
P/E Ratio
Forward P/E: 16.04
Revenue Growth
Year over Year
Analyst Target
+2.7% upside potential
Key Investor Questions About KVUE
What investors need to know before buying
Based on current market data, KVUE presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 49.08)
- Fundamentals say: Caution warranted (high leverage concerns)
KVUE's growth trajectory depends on its ability to expand within the Software sector while managing margin pressures.
- Future growth will depend on performance in core Software operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for KVUE investors include debt exposure and competitive dynamics in the Software industry.
- $8.80B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Software.
52-Week Trading Range
Over the past year, KVUE stock traded between $14.02 and $22.87—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 20.25% annualized volatility and β=0.21, the stock exhibits low sensitivity to market moves—making KVUE suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
VOYA Stock Hits Record High, Tops $100 For The First Time Ever – Report Says Voya Financial Has Been ‘Fielding’ Takeover Interest
The report said Principal Financial had expressed interest earlier this year, but nothing came of the approach.
4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential
While growth investors scrambled for cover in 2026, a quiet group of battle-tested income stocks started leaving the S&P 500 in the dust. Four Dividend Kings with decades of unbroken payouts are now posting returns that would make most momentum traders jealous, and Wall Street thinks they still have room to run.
Sector Update: Healthcare Stocks Advance Late Afternoon
Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and
KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits
A federal appeals court has revived hundreds of lawsuits claiming that Tylenol use during pregnancy can increase the risk of autism and ADHD in children.
Top Midday Stories: Trump Says US to Be Guardian of Hormuz Strait; Meta to Invest Over $50 Billion in Louisiana Data Center Expansion
All three major US stock indexes were down in late-morning trading Monday, as the US and Iran exchan
Tylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says
(Bloomberg) -- A federal appeals court revived lawsuits that claim Kenvue Inc. hid alleged risks that Tylenol could cause autism in children whose mothers took the over-the-counter pain medication while pregnant, a controversy that’s roiled the medical community.Most Read from BloombergLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Trump Embraces Australian Retirement System Backed by Larry FinkHormuz Route Open Despite Iran Declaration, Maritime Group SaysOpenAI Engineer’s ‘LOL’ Momen
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance. For retail investors scanning for value, the sub-$30 shelf in healthcare currently offers exposure to a pending strategic ... 3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Kenvue (KVUE) Stock May Be A Bargain Despite The Acquisition Bid
Kenvue stock has climbed 14.5% over the past month, yet there is a clear split in what different valuation lenses are saying, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings based multiples lean the other way. The 14.5% gain over the past month suggests sentiment around Kenvue has improved quickly, raising the question of how much of that optimism is already reflected in the price. The planned US$48.7b acquisition of Kenvue by Kimberly...
5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential
Passive income is characterized by its ability to generate revenue without requiring the earner’s continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence. The more passive income can help cover rising costs, such as mortgages, insurance, taxes, and other expenses, the easier it ... 5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential
Kenvue (KVUE) Faces A $48.7 Billion Kimberly Clark Deal And Big Portfolio Questions
Kimberly-Clark has announced a planned $48.7b acquisition of Kenvue (NYSE:KVUE). The transaction is expected to lead to a change in ownership and integration of Kenvue into Kimberly-Clark's consumer products portfolio. Investors are watching for updates on how the deal could affect Kenvue's operations, capital allocation and brand priorities. Kenvue, trading on the NYSE under the ticker KVUE, last closed at $19.33, with the stock up 2.8% over the past week and 11.4% over the past month...
Frequently Asked Questions
Common investor questions about KVUE
KVUE (KVUE) is currently trading at $18.98. The RSI (14-day) is at 49.1, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $19.50 implies 2.7% upside from current levels. Volatility is moderate at 20.3% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for KVUE (KVUE): The trailing P/E ratio is 22.60, which is in line with broader market averages. The forward P/E is 16.04, lower than the trailing P/E, suggesting analysts expect earnings improvement. Price-to-Book is 3.44. Price-to-Sales is 2.38. Valuation should be compared to Software industry peers for context, as different sectors trade at different multiples.
Based on 12 analysts covering KVUE, the consensus price target is $19.50. This represents a 2.7% upside from the current price of $18.98. The range spans from a low target of $18.00 to a high target of $23.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, KVUE (KVUE) pays a dividend with a current yield of approximately 4.37%. The annualized dividend rate is $0.83 per share. The payout ratio is 98.5%, which is relatively high—earnings cover the dividend but there's limited room for increases. The most recent ex-dividend date was 2026-05-13T00:00:00.000Z.
Key risks for KVUE (KVUE) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Software sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is KVUE's (KVUE) current debt and financial health profile: Total debt stands at $8.80B. The debt-to-equity ratio is 82.97, which is elevated and warrants monitoring, especially in a rising interest rate environment. The current ratio is 0.98, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.61. The company holds $1.08B in cash and equivalents. Free cash flow is positive at $1.86B, providing a cushion for debt servicing and shareholder returns.